Executive Summary
The pharmacy project in the medical and health sector in France targets a promising market opportunity. With an investment of €٣٥٠,٠٠٠, it achieves a Net Present Value of -€١١٦,١٠٢, an Internal Rate of Return of -٢%, and a payback period of — years.
| Indicator | Value |
|---|---|
| Initial Investment | €٣٥٠,٠٠٠ |
| First Year Revenue | €٢١٠,٠٠٠ |
| Annual Growth (CAGR) | ١٢% |
| Net Margin (Y1) | -٨% |
| Return on Investment (Avg.) | -١% annually |
| Net Present Value (NPV) | -€١١٦,١٠٢ |
| Internal Rate of Return (IRR) | -٢% |
| Profitability Index (PI) | ١ |
| Payback Period | — |
| Breakeven Year | — |
| Expected NPV (Probability-Weighted) | -€١١٣,٠٣٧ |
Assumptions and Basis
The figures in this study are based on project data, the nature of the medical and health sector in France, and local market indicators, according to the following assumptions:
| Assumption | Value |
|---|---|
| Initial Capital | €٣٥٠,٠٠٠ |
| First Year Revenue | €٢١٠,٠٠٠ |
| Annual Growth | ١٢% |
| Cost of Goods Sold (COGS) | ٣٥% of Revenue |
| Operating Expenses | ٤٠% of Revenue |
| Tax/Zakat | ٥% |
| Discount Rate (WACC) | ١٢% |
| Study Horizon | ٥ years |
Project Description and Opportunity
The pharmacy offers clear value in the medical and health sector through a business model focused on a specific segment.
Market and Demand Study
Growing demand driven by changing behavior and spending.
Market Sizing (TAM / SAM / SOM)
| Level | Annual Size | Description |
|---|---|---|
| TAM — Total Addressable Market | €٠ | Total demand serviceable |
| SAM — Serviceable Available Market | €٠ | Portion reachable by your model |
| SOM — Serviceable Obtainable Market | €٠ | Your realistic early share |
Competitive Analysis
Sustainable advantage through quality and brand.
Market Entry and Pricing Plan
Digital and direct channels with competitive pricing.
Capacity and Operations
Operations with clear procedures and scalable capacity.
Projected Income Statement (5 Years)
| Item \ Year | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Revenue | €٢١٠,٠٠٠ | €٢٣٥,٢٠٠ | €٢٦٣,٤٢٤ | €٢٩٥,٠٣٥ | €٣٣٠,٤٣٩ |
| Cost of Sales | (€٧٣,٥٠٠) | (€٨٢,٣٢٠) | (€٩٢,١٩٨) | (€١٠٣,٢٦٢) | (€١١٥,٦٥٤) |
| Gross Profit | €١٣٦,٥٠٠ | €١٥٢,٨٨٠ | €١٧١,٢٢٦ | €١٩١,٧٧٣ | €٢١٤,٧٨٥ |
| Operating Expenses | (€٨٤,٠٠٠) | (€٩٤,٠٨٠) | (€١٠٥,٣٧٠) | (€١١٨,٠١٤) | (€١٣٢,١٧٦) |
| EBITDA | €٥٢,٥٠٠ | €٥٨,٨٠٠ | €٦٥,٨٥٦ | €٧٣,٧٥٩ | €٨٢,٦١٠ |
| Tax | (€٠) | (€٠) | (€٠) | (€١٨٨) | (€٦٣٠) |
| Net Profit | -€١٧,٥٠٠ | -€١١,٢٠٠ | -€٤,١٤٤ | €٣,٥٧١ | €١١,٩٧٩ |
| Net Margin | -٨% | -٥% | -٢% | ١% | ٤% |
Investment Cost Structure
| Item | Cost | Percentage |
|---|---|---|
| Equipment and Setup | €١٢٢,٥٠٠ | ٣٥% |
| Working Capital | €١٠٥,٠٠٠ | ٣٠% |
| Marketing and Launch | €٥٢,٥٠٠ | ١٥% |
| Licenses and Establishment | €٤٢,٠٠٠ | ١٢% |
| Emergency Reserve | €٢٨,٠٠٠ | ٨% |
Cash Flow and Breakeven Point
| Year | Operating Cash Flow | Cumulative Cash Flow |
|---|---|---|
| Year 1 | €٥٢,٥٠٠ | -€٢٩٧,٥٠٠ |
| Year 2 | €٥٨,٨٠٠ | -€٢٣٨,٧٠٠ |
| Year 3 | €٦٥,٨٥٦ | -€١٧٢,٨٤٤ |
| Year 4 | €٧٣,٥٧١ | -€٩٩,٢٧٣ |
| Year 5 | €٨١,٩٧٩ | -€١٧,٢٩٤ |
Estimated breakeven point at an annual revenue of ≈ €٢٣٦,٩٢٣ (~١١٣% of first year revenue), with a contribution margin of ٦٥%. Cumulative cash breakeven is beyond the study horizon.
Funding Structure
| Funding Source | Percentage | Amount |
|---|---|---|
| Equity | ٧٠% | €٢٤٥,٠٠٠ |
| Debt Financing (٨% interest) | ٣٠% | €١٠٥,٠٠٠ |
Sensitivity Analysis (Revenue × Operations)
Impact of combined changes in revenue and costs on Net Present Value:
| Revenue \ Operations | −10% | −5% | Base | +5% | +10% |
|---|---|---|---|---|---|
| −20% | -€٨٨,٦٧٣ | -€١٢٥,٢٩٠ | -€١٦٢,٥٠٠ | -€٢٠٠,٠٠٠ | -€٢٣٧,٥٠٠ |
| −10% | -€٥٧,٠٠٨ | -€٩٧,٧٦٧ | -€١٣٩,١٨٦ | -€١٨١,٢٥٠ | -€٢٢٣,٤٣٧ |
| Base | -€٢٥,٦٦٥ | -€٧٠,٥٠٨ | -€١١٦,١٠٢ | -€١٦٢,٥٠٠ | -€٢٠٩,٣٧٥ |
| +10% | €٥,٥٠٧ | -€٤٣,٥٠٨ | -€٩٣,٢٢٠ | -€١٤٣,٨٢٦ | -€١٩٥,٣١٢ |
| +20% | €٣٦,٦٧٩ | -€١٦,٧٥٨ | -€٧٠,٥٠٨ | -€١٢٥,٢٩٠ | -€١٨١,٢٥٠ |
Scenario Analysis
| Scenario | Probability | NPV | Assessment |
|---|---|---|---|
| Pessimistic | ٢٥% | -€١٩٢,٥٠٠ | Not Viable |
| Base | ٥٠% | -€١١٦,١٠٢ | Not Viable |
| Optimistic | ٢٥% | -€٢٧,٤٤٦ | Not Viable |
Expected Present Value (Weighted): -€١١٣,٠٣٧.
Risk Analysis and Management
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| Demand Volatility | Medium | Medium | Diversify Channels |
| Cost Increases | Medium | High | Supply Contracts |
| Competition | High | Medium | Brand Differentiation |
Organizational Structure and Team
Core team with administrative, technical, and marketing competencies.
Legal and Regulatory Aspects
Completion of licenses and regulatory compliance in France.
Expansion and Sustainability Plan
Geographic/product expansion after model validation.
Environmental, Social, and Governance (ESG) Impact
Resource optimization, employment opportunities, and sustainable practices.
Conclusions and Recommendations
It is recommended to review pricing and cost structure before proceeding.
Sources and Disclaimer
- Estimates based on sector benchmarks
Disclaimer: This is a guiding study that provides financial analysis according to accepted sector benchmarks; verify the figures locally according to your project's reality before making any investment decision.
